Literature DB >> 27428006

The fundamental importance of smoking cessation in those with premature ST-segment elevation acute myocardial infarction.

Loukianos S Rallidis1, George Pavlakis.   

Abstract

PURPOSE OF REVIEW: Smoking is the most prevalent risk factor among young patients suffering acute myocardial infarction (AMI). In this review, we will present data on the detrimental consequences of continued smoking with regard to the recurrence of coronary events after an AMI at an early age. RECENT
FINDINGS: A prospective study with long-term follow-up of young survivors of AMI showed that continuation of smoking after a first episode of AMI was the strongest independent predictor of further cardiac events. In particular, persistent smokers had ∼2.5 times higher risk of a new coronary event when compared with nonsmokers. This emphasizes the fundamental importance of initiating smoking cessation treatment in all smokers with AMI during hospitalization. Extrapolating the results of previous studies showing the benefits of smoking cessation in middle-aged or elderly coronary patients, an even greater benefit should be expected in young patients because of their specific characteristics, which are presented in the current review.
SUMMARY: Young persistent smokers after a premature AMI constitute a high-risk subgroup for a recurrence of cardiac events. Therefore, smoking cessation is a key issue for improving their prognosis and all smokers should be offered effective antismoking treatment at the time of initial hospitalization.

Entities:  

Mesh:

Year:  2016        PMID: 27428006     DOI: 10.1097/HCO.0000000000000320

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  5 in total

1.  Using Machine Learning Techniques to Predict MACE in Very Young Acute Coronary Syndrome Patients.

Authors:  Pablo Juan-Salvadores; Cesar Veiga; Víctor Alfonso Jiménez Díaz; Alba Guitián González; Cristina Iglesia Carreño; Cristina Martínez Reglero; José Antonio Baz Alonso; Francisco Caamaño Isorna; Andrés Iñiguez Romo
Journal:  Diagnostics (Basel)       Date:  2022-02-06

2.  Effect of factor XIII levels and polymorphisms on the risk of myocardial infarction in young patients.

Authors:  László Balogh; Éva Katona; Zoltán A Mezei; Judit Kállai; Réka Gindele; István Édes; László Muszbek; Zoltán Papp; Zsuzsanna Bereczky
Journal:  Mol Cell Biochem       Date:  2018-02-26       Impact factor: 3.396

3.  Differences in Angiographic Profile and Immediate Outcome of Primary Percutaneous Coronary Intervention in Otherwise Risk-Free Young Male Smokers.

Authors:  Salik Ahmed; Sanam Khowaja; Saher Khowaja; Tariq Ashraf; Kanwal Aamir; Mahesh K Batra; Musa Karim; Muhammad Anis M Ahmedani; Syed Z Jamal
Journal:  Cureus       Date:  2020-06-24

4.  Associations of ACE I/D polymorphism with the levels of ACE, kallikrein, angiotensin II and interleukin-6 in STEMI patients.

Authors:  Shuhong Dai; Mei Ding; Na Liang; Zhuo Li; Daqing Li; Lianyue Guan; Hongyu Liu
Journal:  Sci Rep       Date:  2019-12-23       Impact factor: 4.379

5.  Clinical Features and Long-Term Outcomes in Very Young Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries.

Authors:  Pablo Juan-Salvadores; Víctor Alfonso Jiménez Díaz; Ana Rodríguez González de Araujo; Cristina Iglesia Carreño; Alba Guitián González; Cesar Veiga Garcia; José Antonio Baz Alonso; Francisco Caamaño Isorna; Andrés Iñiguez Romo
Journal:  J Interv Cardiol       Date:  2022-07-30       Impact factor: 1.776

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.